Neurology Devices

REPORT HIGHLIGHTS

Global Neurology Devices Market to Reach US$20.8 Billion by 2032

The global market for Neurology Devices estimated at US$13.9 Billion in the year 2025, is expected to reach US$20.8 Billion by 2032, growing at a CAGR of 6.0% over the analysis period 2025-2032. Neurostimulation Devices, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$6.6 Billion by the end of the analysis period. Growth in the Neurosurgical Devices segment is estimated at 7.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.3 Billion While China is Forecast to Grow at 9.5% CAGR

The Neurology Devices market in the U.S. is estimated at US$4.3 Billion in the year 2025. China, the world`s second largest economy, is forecast to reach a projected market size of US$5.2 Billion by the year 2032 trailing a CAGR of 9.5% over the analysis period 2025-2032. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.1% and 6.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global Neurology Devices Market - Key Trends & Drivers Summarized

How Are Neurology Devices Advancing the Treatment of Neurological Disorders?

Neurology devices have become integral in diagnosing, monitoring, and treating a wide range of neurological disorders, from epilepsy and Parkinson`s disease to stroke and traumatic brain injury. These devices encompass a broad range of technologies, including neurostimulation devices, neurodiagnostic systems, and cerebrospinal fluid management equipment. With neurological disorders on the rise due to aging populations and increasing awareness of mental health conditions, the demand for these devices has grown exponentially. Innovations such as deep brain stimulation (DBS) for treating movement disorders, as well as advanced imaging technologies like electroencephalograms (EEGs), are enabling more precise and less invasive diagnosis and treatment options, significantly improving patient outcomes.

What Role Does Technology Play in Shaping Neurology Device Innovations?

The advancement of neurology devices is closely tied to technological innovations in fields like robotics, artificial intelligence (AI), and miniaturization. AI-powered diagnostic tools are enhancing the ability to detect neurological disorders early, while robotic-assisted surgery is increasing the precision and safety of neurosurgical procedures. Additionally, wearable neurostimulation devices, which deliver low-frequency electrical pulses to treat conditions like migraines or depression, are providing non-invasive alternatives to medication. Miniaturization has enabled the development of smaller, implantable devices, making treatments like DBS more comfortable and accessible for patients. These advancements are not only expanding the capabilities of neurology devices but also improving the quality of life for individuals with neurological conditions.

How Are Demographic and Healthcare Trends Impacting the Neurology Devices Market?

The growing prevalence of neurological disorders, particularly among aging populations, is a key factor driving demand for neurology devices. Conditions such as Alzheimer’s disease, stroke, and Parkinson’s are becoming more common, requiring advanced devices for both diagnosis and long-term management. In addition, increased healthcare spending and a rising focus on improving the quality of neurological care are spurring investments in new technologies and therapies. Emerging markets are also seeing a surge in demand for neurology devices as healthcare infrastructure improves, and awareness of neurological disorders rises. Meanwhile, regulatory bodies are streamlining approval processes for neurology devices that demonstrate significant therapeutic benefits, further driving market growth.

The Growth in the Neurology Devices Market Is Driven by Several Factors

The growth in the neurology devices market is driven by several factors, including the rising incidence of neurological disorders, particularly in aging populations, which is creating greater demand for advanced diagnostic and therapeutic devices. Technological advancements, such as AI-driven diagnostics, robotic-assisted surgeries, and wearable neurostimulation devices, are enhancing the precision and effectiveness of these treatments. Additionally, increasing healthcare expenditure, particularly in emerging markets, is making these advanced devices more accessible. Moreover, the trend toward non-invasive treatment options and improved patient outcomes is prompting healthcare providers to adopt newer, more sophisticated neurology devices. The expanding regulatory support for innovative neurology devices is further fueling the market, as faster approvals are encouraging the adoption of cutting-edge technologies.

SCOPE OF STUDY:

The report analyzes the Neurology Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Device (Neurostimulation Devices, Neurosurgical Devices, Interventional Neurology Devices, Brain-Computer Interface Devices, Other Devices); Application (Chronic Pain Management Application, Parkinson`s Disease Application, Epilepsy Application, Stroke Management & Recovery Application, Alzheimer`s Application, Other Applications); End-Use (Hospitals End-Use, Ambulatory Surgery Centers End-Use, Other End-Uses)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

SELECT PLAYERS -

• Abbott Laboratories, Inc.
• B. Braun Melsungen AG
• Boston Scientific Corporation
• Johnson & Johnson
• Medtronic, Inc.
• MicroPort Scientific Corporation
• Nihon Kohden Corporation
• Penumbra, Inc.
• Smith & Nephew PLC
• Stryker Corporation

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher. Show more